Palomino Laboratories (PALX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PALX Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding Palomino Laboratories's financial stability and long-term positioning.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent19.44
Cash & Short-term Investments19.00
Total loans net0.15
Total Current Assets19.59
Equipment/Property/Plant Net1.26
Tax Assets, Noncurrent0.00
Deferred, Prepaid and Other Assets, Noncurrent0.00
Other Assets, Noncurrent0.19
Total Assets21.04
Liabilities
Accounts Payable0.16
Accrued Liabilities, Current0.21
Short-term Debt0.00
Total Current Liabilities0.37
Total Long-term Debt0.00
Other liabilities, Noncurrent0.11
Total Liabilities0.48
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock26.35
Retained Earnings / Accumulated Deficit-5.79
Common Stockholder's Equity20.57
Total Stockholder's Equity20.57
Liabilities & Stockholder's Equity21.04
4 historic quarters locked

Sign in to unlock the full Palomino Laboratories balance sheet history.

About Palomino Laboratories Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 4, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-036061

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.